Yamaguchi Tomoya, Lu Can, Ida Lisa, Yanagisawa Kiyoshi, Usukura Jiro, Cheng Jinglei, Hotta Naoe, Shimada Yukako, Isomura Hisanori, Suzuki Motoshi, Fujimoto Toyoshi, Takahashi Takashi
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Division of Integrated Project, EcoTopia Science Institute, Nagoya University, Nagoya 464-8603, Japan.
Nat Commun. 2016 Jan 4;7:10060. doi: 10.1038/ncomms10060.
The receptor tyrosine kinase-like orphan receptor 1 (ROR1) sustains prosurvival signalling directly downstream of the lineage-survival oncogene NKX2-1/TTF-1 in lung adenocarcinoma. Here we report an unanticipated function of this receptor tyrosine kinase (RTK) as a scaffold of cavin-1 and caveolin-1 (CAV1), two essential structural components of caveolae. This kinase-independent function of ROR1 facilitates the interactions of cavin-1 and CAV1 at the plasma membrane, thereby preventing the lysosomal degradation of CAV1. Caveolae structures and prosurvival signalling towards AKT through multiple RTKs are consequently sustained. These findings provide mechanistic insight into how ROR1 inhibition can overcome EGFR-tyrosine kinase inhibitor (TKI) resistance due to bypass signalling via diverse RTKs such as MET and IGF-IR, which is currently a major clinical obstacle. Considering its onco-embryonic expression, inhibition of the scaffold function of ROR1 in patients with lung adenocarcinoma is an attractive approach for improved treatment of this devastating cancer.
受体酪氨酸激酶样孤儿受体1(ROR1)在肺腺癌中维持谱系存活癌基因NKX2-1/TTF-1直接下游的促存活信号传导。在此,我们报告了这种受体酪氨酸激酶(RTK)作为小窝蛋白-1和小窝蛋白-1(CAV1)支架的意外功能,小窝蛋白-1和小窝蛋白-1是小窝的两个重要结构成分。ROR1的这种不依赖激酶的功能促进了小窝蛋白-1和CAV1在质膜上的相互作用,从而防止CAV1的溶酶体降解。因此,小窝结构和通过多种RTK向AKT的促存活信号传导得以维持。这些发现为ROR1抑制如何克服由于通过MET和IGF-IR等多种RTK的旁路信号传导导致的EGFR酪氨酸激酶抑制剂(TKI)耐药性提供了机制性见解,这是目前一个主要的临床障碍。鉴于其胚胎癌表达,抑制肺腺癌患者中ROR1的支架功能是改善这种毁灭性癌症治疗的一种有吸引力的方法。